Bleomycin, Etoposide, and Cisplatin Combination Therapy of Ovarian Granulosa Cell Tumors and Other Stromal Malignancies: A Gynecologic Oncology Group Study-Reference-Cited by-同舟云学术

Bleomycin, Etoposide, and Cisplatin Combination Therapy of Ovarian Granulosa Cell Tumors and Other Stromal Malignancies: A Gynecologic Oncology Group Study

Published:1999-02 Issue:2 Volume:72 Page:131-137
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Homesley Howard D.,Bundy Brian N.,Hurteau Jean A.,Roth Lawrence M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference27 articles.

1. Granulosa cell tumor of the ovary: a clinicopathological evaluation of 60 cases;Ayhan;Eur J Gynaecol Oncol,1994

2. Radiotherapy or chemotherapy in malignant stromal tumors of the ovary;Slayton;Proc Am Soc Clin Oncol,1980

3. Combination chemotherapy of ovarian granulosa cell tumor with cisplatin and doxorubicin;Jacobs;Gynecol Oncol,1982

4. Chemotherapy of granulosa cell tumors;Camlibel;Am J Obstet Gynecol,1983

5. Cyclophosphamide, adriamycin, andcis;Kaye;Gynecol Oncol,1986

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14;Gynecologic Oncology;2024-11

2. Ovarian steroid cell tumors, not otherwise specified: three case reports and literature review;Frontiers in Oncology;2024-07-04

3. Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries;Gynecologic Oncology;2024-07

4. Combination of Etoposide and quercetin-loaded solid lipid nanoparticles Potentiates apoptotic effects on MDA-MB-231 breast cancer cells;Heliyon;2024-06

5. Complete reduction surgery of a huge recurrent adult granulosa cell tumor after neoadjuvant chemotherapy;International Cancer Conference Journal;2024-02-14